BOSTON, Sept. 30 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company intends to expand their current industry to include and capitalize on the $30 billion minimally invasive instrumentation market by implementing a business strategy. The Company's strategy is expected to substantially increase its revenue, and simultaneously increase its customer base.
Solos Endoscopy expects continuous growth in this market because physicians are developing new minimally invasive techniques, not only in the traditional area of general surgery, but also in other medical specialty areas. This shift in the Company's business strategy will allow many more procedures to be performed outside the operating room setting and this expansion creates an increased demand for high quality instrumentation in the medical product market.
"Our initiative for 2008 is to enhance the instrumentation that we have developed in the general surgery line, and to move our surgical instrument division into diverse specialties. We believe that we have a great future; our reputation in the medical industry is that we build excellent instruments and this, coupled with our new products, will significantly expand our revenue and customer base in the future," stated Robert Segersten, President of Solos Endoscopy, Inc.
For additional information on Solos Endoscopy, Inc. please visit http://www.solosendoscopy.com .
About Solos Endoscopy, Inc.
Solos Endoscopy, Inc. is a healthcare technology company whose mission
is to develop and market breakthrough technology, applications, medical
devices, and procedural techniques for the screening, diagnosis, treatment
and management of disease and medical conditions. Backed by technical
support, Solos' sales team can help make the right buying decisions for the
hospital, surgery center, or physician office. Additional informa
|SOURCE Solos Endoscopy, Inc.|
Copyright©2008 PR Newswire.
All rights reserved